Compare CTMX & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTMX | METC |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | 900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 977.1M | 1.0B |
| IPO Year | 2015 | N/A |
| Metric | CTMX | METC |
|---|---|---|
| Price | $3.73 | $13.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $12.10 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 2.9M | 1.4M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $76,201,000.00 | N/A |
| Revenue This Year | N/A | $19.61 |
| Revenue Next Year | $7.61 | $11.96 |
| P/E Ratio | $22.58 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.72 | $8.51 |
| 52 Week High | $8.21 | $57.80 |
| Indicator | CTMX | METC |
|---|---|---|
| Relative Strength Index (RSI) | 38.55 | 40.09 |
| Support Level | $3.39 | N/A |
| Resistance Level | $3.91 | $16.20 |
| Average True Range (ATR) | 0.21 | 1.08 |
| MACD | -0.02 | -0.18 |
| Stochastic Oscillator | 32.46 | 4.58 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.